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Abstract
Background: The role of laparoscopic resection in patients with clinically suspicious T4 colorectal cancer
remains controversial. The aim of this study was to compare the long-term and oncologic outcomes of
laparoscopic resection and the open approach in clinical T4 colorectal cancer.
Methods: Two hundred ninety-three consecutive patients undergoing curative surgery for colorectal cancer
suspected to be T4 by computed tomography and/or magnetic resonance imaging were reviewed.
Results: Despite clinical suspicion of T4 disease in all cases, concordance with pathologic determination of
T4 was only 37.9 %. Of the 71 patients in the laparoscopic group, four (5.6 %) were converted to the open
technique. Patients in the laparoscopic group had significantly lower estimated blood loss (p < 0.001), fewer
days to first flatus (p = 0.001), shorter length of hospital stay (p < 0.001), and fewer adverse events (14.1 % versus 31.5 %,
p = 0.004). After a median follow-up of 36 months, 5-year disease-free survival was not significantly different between
the two groups (81.8 % in laparoscopic versus 73.9 % in open surgery, p = 0.433). The clinical factors that predicted T4
staging on pathologic examination were found to be male sex (p = 0.038), preoperative carcinoembryonic antigen
status (p = 0.021), clinical N status (p = 0.046), and clinical cancer perforation (p = 0.004).
Conclusions: Laparoscopic colorectal resection for T4 colorectal cancer has perioperative and long-term oncologic
outcomes similar to those of the open approach when performed by an experienced surgeon.
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Background
Laparoscopic surgery is a well-established treatment ap-
proach for colorectal cancer. Several randomized studies
have reported that the laparoscopic approach is associ-
ated with decreased postoperative pain, shorter hospital
stay, and reduced postoperative adverse events com-
pared to conventional surgery [1–4]. Recently, the guide-
lines from the American Society of Colon & Rectal
Surgeons (ASCRS) and the European Association of
Endoscopic Surgery have suggested that a laparoscopic
approach is the optimal technique for colorectal cancer
resection [5–7].
However, the role of laparoscopic resection in patients
with clinically suspected T4 colorectal cancer remains
controversial. The concerns regarding laparoscopy at
this stage of disease include higher risk of conversion
and lower quality of oncologic resection. It is recom-
mended that resection for locally advanced colorectal
cancer be performed via an open approach, according to
the Society of American Gastrointestinal and Endoscopic
Surgeons guidelines (SAGES); however, the ASCRS
guidelines suggest that laparoscopic and open colecto-
mies result in equivalent oncological outcomes for local-
ized colon cancer [5, 7].
There are several studies showing that a laparoscopic
approach in locally-advanced colorectal cancer is a feas-
ible and effective treatment option, but little information
is currently available [8–13]. Thus, the aim of this study
was to compare the long-term and oncologic outcomes
of laparoscopic resection and open approach for clinic-
ally suspected T4 colorectal cancer.
Methods
Patients who underwent colorectal cancer surgery from
January 2000 to December 2010 were analyzed. Patients
with pathologically confirmed primary colorectal cancer
who underwent curative resection and had clinically suspi-
cious T4 disease were included in this study. Patients with
no recorded clinical T stage, recurrent colorectal cancer,
distal metastasis, familial adenomatous polyposis (FAP),
hereditary non-polyposis colorectal cancer (HNPCC),
local resection, clinical T0-3 disease, or neoadjuvant che-
moradiotherapy were excluded.
The charts of 293 consecutive patients who had under-
gone curative surgery for colorectal cancer with a perfo-
rated tumor and/or suspected involvement of another
organ (T4) diagnosed by computed tomography (CT) and/
or magnetic resonance imaging (MRI) were reviewed. Of
these patients, 71 (24.2 %) underwent laparoscopic colorec-
tal resection, and 222 (75.8 %) underwent open resection.
Demographic data including age, sex, body mass index
(in kilograms per meter squared, BMI), ASA (American
Society of Anesthesiologists) score, preoperative carci-
noembryonic antigen (CEA) level, previous abdominal
operation history, tumor location, clinical T or N cat-
egory, cancer obstruction or perforation, pathologic fea-
tures (proximal and distal resection margin, the seventh
American Joint Committee on Cancer (AJCC) TNM
tumor stage, lymphatic invasion, vascular invasion, and
perineural invasion), and adjuvant chemotherapy were
collected and analyzed. In addition, we also collected
and analyzed data on perioperative clinical outcomes
(operative time; blood loss; days to first flatus; days to
first diet; length of hospital stay; diverting stoma; and
postoperative adverse events including anastomotic leak-
age, type of laparoscopic surgery, and open conversion
rate). Clinical factors related to pathologic T4 stage were
analyzed for the whole cohort and clinicopathologic fac-
tors for survival were also evaluated. All colorectal resec-
tions were performed with curative intent. This study
was approved by the Institutional Review Board of
Samsung Medical Center, Sungkyunkwan University.
All patients underwent physical examination, measure-
ment of serum CEA level, colonoscopy, chest CT, and
abdominopelvic CT or pelvic MRI for preoperative clin-
ical staging. Positron emission tomography (PET) scan-
ning was used to assess the extent of lymph node
metastasis and distal metastasis, if indicated. T4 disease
was preoperatively suspected in cases with a perforated
tumor and/or invasion of adjacent organs on the above-
mentioned preoperative imaging studies. Patients were
followed-up at 3-month intervals for 2 years, at 6-month
intervals for the next 3 years, and annually thereafter.
On a semiannual basis or when there was suspicion of
recurrence, follow-up examinations including a clinical
history, physical examination, serum CEA assay, chest
CT, abdominopelvic CT or MRI, colonoscopy, or PET
scanning were performed. Recurrence was determined
by clinical and radiological examination or by histologic
confirmation. The main pattern of recurrence was re-
corded as the first site of detectable failure during the
follow-up period.
Statistical analyses were carried out using the Statis-
tical Package for the Social Sciences for Windows, ver-
sion 18.0 (SPSS, Chicago, IL, USA). The significance of
differences between groups was evaluated using the Chi-
square test or analysis of variance, as appropriate.
Survival rates were calculated using the Kaplan-Meier
method, and prognostic factors and survival curves were
compared using log-rank tests. Factors that were signifi-
cant (p ≤ 0.1) upon univariate analysis were entered into
multivariate analysis using the Cox model. A P-value of
0.050 or less was considered statistically significant.
Results
The demographic features of the open and laparoscopic
groups are presented in Table 1. There were no differ-
ences in age, sex, ASA score, previous operative history,
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tumor location, or clinical N stage. BMI was higher in
the laparoscopic resection group than in the open sur-
gery group (p = 0.011). In addition, preoperative CEA
level, combined resection of an adjacent organ, propor-
tion of clinical T4b, cancer obstruction, and perforation
were significantly higher in the open surgery group com-
pared to the laparoscopic surgery group (Table 1). The
median follow-up period was 36.0 months (range, 0 –
121 months).
When comparing pathologic outcomes, pathologic T
stage, tumor size, and the number of harvested lymph
nodes were significantly higher in the open surgery
group. In addition, pathologic N stage and TNM stage
in the laparoscopic surgery group were higher than those
in the open group, although these differences were not
statistically significant. Analysis of perioperative clinical
outcomes showed no differences in operative time, di-
verting stoma, or clinical anastomotic leakage between
groups. However, blood loss (175.0 ml versus 100.0 ml,
p < 0.001) and overall postoperative adverse events
(31.5 % versus 14.1 %, p = 0.004) in the open surgery
group were higher than those in the laparoscopic surgery
group. In addition, the number of days to first flatus
(4.0 days versus 3.0 days, p = 0.001), days to first diet
(5.0 days versus 4.0 days, p = 0.008), and length of hos-
pital stay (12.0 days versus 9.0 days, p < 0.001) were
shorter in the laparoscopic surgery group. The types of
laparoscopic surgery modalities were as follows: 59.1 %
(42 patients) underwent hand-assisted laparoscopic sur-
gery, 31.0 % (22 patients) had conventional laparoscopic
surgery, and 9.9 % (7 patients) had a single-incisional
laparoscopic surgery. Postoperative adverse events oc-
curred in 70 patients (31.5 %) in the open group, but in
only 10 patients (14.1 %) in the laparoscopic group (p =
0.004). The primary adverse events were ileus (9.9 (22/
222) in open surgery and 2.8 % (2/71) in laparoscopic
surgery) and wound seroma (5.4 % (12/222) versus 4.2 %
(3/71), respectively). Cases of anastomotic leakage did
not differ significantly between the two groups, with
nine patients (4.1 %) experiencing leakage in the open
group versus one patient (1.4 %) in the laparoscopic
group (p = 0.285). Notably, four (5.6 %) patients under-
went open conversion during laparoscopic surgery;
pneumoperitoneum could not be sustained during the
operation for one patient, a suspected metastatic lymph
node beyond the surgical plane was identified during the
laparoscopic approach with severe adhesion in another
patient, the surgical field could not be secured because
of severe bowel edema due to partial obstruction of can-
cer in another patient, and localized abscess due to can-
cer perforation with severe adhesion was found in
another patient (Table 2).
According to multivariate analysis, the single clinically
predictive factor of pathologic T4 staging was clinically
suspicious perforation (p = 0.024) (Table 3). Multivariate
analysis also showed the strongest independent prognos-
tic factors predicting lower disease-free survival to be
age (>60) (p = 0.036), preoperative CEA level (>5 ng/ml)
(p = 0.032), tumor location (rectum) (p < 0.001), and
pathologically confirmed T4 staging (p = 0.006). Op-
erative technique was not found to affect prognosis
(Table 4). In addition, 5-year disease free survival
(DFS) and 5-year overall survival (OS) in the laparo-
scopic surgery group were not statistically different
from those of the open surgery group (81.8 versus
73.9 (p = 0.433), and 95.3 % versus 86.5 % (p = 0.220),
respectively) (Fig. 1).




n = 222 n = 71
Age (years) 0.321
median (range) 61.0 (17–84) 59.0 (36–80)
Sex 0.372
Female 96 (43.2 %) 35 (49.3 %)
Male 126 (56.8 %) 36 (50.7 %)
BMI (kg/m2) 0.011
median (range) 22.6 (15.2-31.3) 23.6 (17.3-31.9)
ASA score 0.377
1 90 (40.5 %) 33 (46.5 %)
2 + 3 + 4 132 (59.5 %) 38 (53.5 %)
Preoperative CEA (ng/ml) 0.005




Negative 48 (21.6 %) 21 (29.6 %)
Positive
Combined resection of an
adjacent organ (%)
73 (32.9 %) 7 (9.9 %) <0.001
Location of tumor (%) 0.956
Right colona 77 (34.70 %) 26 (35.60 %)
Left colona 77 (34.70 %) 24 (33.80 %)
Rectum 68 (30.60 %) 21 (29.60 %)
Clinical T4 status <0.001
T4a 130 (58.6 %) 58 (81.7 %)
T4b 92 (41.4 %) 13 (18.3 %)
Clinical N status 0.523
Negative 9 (4.10 %) 4 (5.60 %)
Positive 213 (95.90 %) 67 (94.40 %)
Cancer obstruction (%) 90 (40.5 %) 17 (23.9 %) 0.011
Cancer perforation (%) 23 (10.4 %) 2 (2.8 %) 0.048
CEA Carcinoembryonic antigen
aThe right colon and left colon were divided by the splenic flexure
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Table 2 Comparison of pathologic outcomes and perioperative clinical outcomes between the open and laparoscopic surgery
groups
Open surgery Laparoscopic surgery P-value
n = 222 n = 71
Perioperative features
Type of surgery 0.296
Right hemicolectomy 69 (31.1 %) 21 (29.6 %)
Transverse colectomy 4 (1.8 %) 0 (0.0 %)
Left hemicolectomy 19 (8.6 %) 6 (8.5 %)
Anterior resection 60 (27.0 %) 24 (33.8 %)
Low anterior resection 52 (23.4 %) 20 (28.2 %)
Hartmann’s operation 9 (4.1 %) 0 (0.0 %)
Abdominoperineal resection 8 (3.6 %) 0 (0.0 %)
Total colectomy 1 (0.5 %) 0 (0.0 %)
Operation time (minutes), median (range) 155.5 (48–708) 155.0 (79–399) 0.249
Blood loss (ml), median (range) 175.0 (20–4200) 100.0 (20–450) <0.001
Days to first flatus (days), median (range) 4.0 (1–67) 3.0 (1–11) 0.001
Days to first solid food (days), median (range) 5.0 (2–69) 4.0 (3–21) 0.008
Length of hospital stay (days), median (range) 12.0 (2–116) 9 (7–27) <0.001
Diverting stoma 8 (3.60 %) 2 (2.8 %) 0.751
Pathologic outcomes
Pathologic T stage no. ( %) T2 9 (4.0 %) 3 (4.2 %) 0.041
T3 120 (54.1 %) 50 (70.4 %)
T4 93 (41.9 %) 18 (25.4 %)
Pathologic N stage no. ( %) 0 118 (53.2 %) 28 (39.4 %) 0.085
1 57 (25.7 %) 27 (38.0 %)
2 47 (21.2 %) 16 (22.5 %)
Tumor size (cm), median (range) 7.0 (1–20) 5.5 (2–12) <0.001
Grade of differentiation no. ( %) 0.136
WD + MD 180 (81.1 %) 63 (88.7 %)
PD + MUC + Signet 42 (18.9 %) 8 (11.3 %)
Lymphatic invasion Negative 143 (64.3 %)a 44 (62.0 %) 0.427
Positive 70 (31.5 %) 27 (38.0 %)
Vascular invasion Negative 173 (77.9 %)b 62 (87.3 %) 0.914
Positive 24 (10.8 %) 9 (12.7 %)
Perineural invasion Negative 176 (79.3 %)c 56 (78.9 %) 0.196
Positive 30 (13.5 %) 15 (21.1 %)
Harvested lymph nodes, median (range) 25.0 (4–138) 20.0 (7–52) <0.001
Proximal resection margin, median (range) 11.0 (2–57) 7.0 (3–28) <0.001
Distal resection margin, median (range) 5.5 (0–55) 4.5 (1–28) 0.241
Adjuvant chemotherapy 171 (77.0 %) 60 (84.5 %) 0.179
Recurrence 35 (15.8 %) 10 (14.1 %) 0.732
Local recurrence 11 (5.0 %) 2 (2.8 %) 0.741
Distant recurrence 24 (10.8 %) 8 (11.3 %) 0.914
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Discussion
A total of 293 consecutive patients with clinically
suspicious T4 cancer were enrolled in this study, and
5-year survival and perioperative outcomes were ana-
lyzed. The perioperative clinical outcomes of laparo-
scopic resection of clinically suspicious T4 colorectal
cancer were more favorable than those of open sur-
gery, with a smaller amount of blood loss, shorter
hospital stay, and fewer postoperative adverse events.
There were no differences in operative time between
the two groups, and the rate of conversion to open
from laparoscopic surgery was only 5.4 % (4/71). Age,
preoperative CEA level, rectal location, clinical ob-
struction and pathologic T stage were associated with
DFS, but operative technique did not affect prognosis.
In addition, 5-year DFS and OS rates were not differ-
ent between the two groups.
Several studies exploring the short-term outcomes of
laparoscopic versus open approaches analyzed patients
with pathologically established T4 disease [12, 14]. In
these studies, it was reported that laparoscopic treat-
ment of T4 colon cancer was safe and feasible and
provided similar surgical and oncological outcomes to
the open technique. However, these studies also showed
that it is difficult to determine the approach modality,
open or laparoscopic, in patients with confirmed patho-
logic T4 disease. In actual clinical settings, the modality
is determined preoperatively based on the results of pre-
operative CT or MRI imaging. Thus, studies exploring
the choice between laparoscopic and open approaches
based on clinical factors in suspected T4 colorectal can-
cer are needed. Some studies exploring this issue have
been reported, but the power of these studies is lacking
due to small sample sizes [8, 11].
In this study, several factors influenced the preopera-
tive decision regarding type of approach. Analysis of
demographic features between the two groups revealed
that these factors included clinical suspicion of T4b dis-
ease, cancer obstruction, and cancer perforation. Clinic-
ally suspected T4b disease compared to T4a disease,
cancer obstruction, and perforation were significantly
more prevalent in the open group than in the laparo-
scopic group. On the other hand, postoperative clinical
N stage did not differ between groups.
Table 2 Comparison of pathologic outcomes and perioperative clinical outcomes between the open and laparoscopic surgery
groups (Continued)
Postoperative complications
Overall 70 (31.5 %) 10 (14.1 %) 0.004
Wound seroma 12 (17.1 %) 3 (30 %)
Wound dehiscence 7 (10.0 %) 0 (0 %)
Paralytic ileus 22 (31.4 %) 2 (20 %)
Mechanical obstruction 2 (2.9 %) 0 (0 %)
Urinary retention 7 (10.0 %) 2 (20 %)
Intraabdominal abscess 2 (2.9 %) 0 (0 %)
Intraabdominal bleeding 1 (1.4 %) 1 (10 %)
Gastrointestinal bleeding 1 (1.4 %) 0 (0 %)
Chylous ascites 2 (2.9 %) 0 (0 %)
Urinary injury 0 (0.0 %) 1 (10 %)
Pneumothorax 1 (1.4 %) 0 (0 %)
Acute myocardial infarction 1 (1.4 %) 0 (0 %)
Pneumonia 2 (2.9 %) 0 (0 %)
Delirium 1 (1.4 %) 0 (0 %)
Anastomotic leakage 9 (12.9 %) 1 (10 %) 0.285
HALS/LAP/SILS 42 (59.1 %)
22 (31.0 %)
7 (9.9 %)
Open Conversion 4 (5.6 %)
WD Well differentiated, MD Moderately differentiated, PD Poorly differentiated, MUC Mucinous adenocarcinoma, signet Signet ring cell type, N/A Not assessed, HALS
Hand-assisted laparoscopic surgery, LAP Conventional laparoscopic surgery, SILS Single-incisional laparoscopic surgery
a N/A 9 (4.2 %) cases
b 25 (11.3 %) cases
c 30 (13.5 %) cases
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Patients have been undergoing laparoscopic surgery
since 2007 when laparoscopic surgery was first per-
formed in a cohort of suspected clinical T4 colon cancer
patients (data not shown). At that time, only one laparo-
scopic colectomy (6.25 %) was performed. Since then,
the proportion of laparoscopic surgeries has increased
gradually up to 41.5 % (39/94) in 2010. Since 2000, when
laparoscopic colectomy first became available for cancer
patients at our institution, the indications for laparo-
scopic procedures have expanded with growing surgeon
experience [15]. According to our results, the open con-
version rate has not changed over time because all four
open conversion cases occurred in 2009. The only
clinical factor found to be significantly predictive of
pathologic T4 disease was clinical cancer perforation;
preoperative CEA level showed a trend toward statistical
significance (p = 0.053). It would be too hard to predict
pathologic T stage by clinical factors alone. One study
reported that the presence of a T4 tumor was a risk fac-
tor for conversion, and conversion to an open approach
during laparoscopic rectal resection was associated with
increased postoperative morbidity [16]. In cases of sus-
pected T4 disease, the choice of approach, laparoscopic
or open, should be made prudently in order to obtain
proper resection margins and to offer better prognosis.
However, the conversion rate could be minimized with
growing surgeon experience. We experienced four
(5.6 %) open conversion cases, and this rate was consid-
ered acceptable in patients with locally-advanced colo-
rectal cancer.
Although there were differences in the number of
harvested lymph nodes between the two groups, the
median number of lymph nodes in the laparoscopic
group was 20, and the number of patients with less
than 12 harvested lymph nodes, as suggested in the
National Comprehensive Cancer Network (NCCN)
guidelines [17], was only 24 (8.2 %) (17 (7.7 %) in
the open group and seven (9.9 %) in the laparoscopic
group, p = 0.556). Despite this, there were no differ-
ences between the two groups in disease-free
survival, distant metastasis, or local recurrence.
Moreover, operative technique was not a significant
prognostic factor for disease free survival in multi-
variate analysis.
Limitations of this study included clinicopathologic
differences between two groups, its single-institution,
retrospective nature, and the small sample size.
However, our results are meaningful despite the po-
tential selection bias because it is difficult to design
a study based on retrospective data. Well-designed
Table 3 Predictive factors for pT4 according to univariate and multivariate analyses
Univariate analysis Multivariate analysis
HR 95 % CI P-value HR 95 % CI P-value
Age (years)
>60 / ≤ 60 0.84 0.52-1.35 0.466
Sex
Male / Female 1.38 0.85-2.23 0.189
BMI (kg/m2)
>23 / ≤ 23 0.82 0.51-1.32 0.423
PreOP CEA (ng/ml)
>5 / ≤ 5 1.85 1.09-3.15 0.022 1.71 0.99-2.94 0.053
Tumor location
Rectum / Colon 0.77 0.46-1.29 0.316
Clinical T4 status
T4b / T4a 1.56 0.96-2.54 0.076 1.43 0.75-2.43 0.179
Clinical N status
+ / - 2.09 0.56-7.75 0.272
Clinical obstruction
+ / - 1.62 0.99-2.63 0.054 1.43 0.85-2.41 0.181
Clinical perforation
+ / - 3.22 1.37-7.56 0.007 2.77 1.15-6.67 0.024
Operative technique
Laparoscopic / Open 0.47 0.26-0.85 0.013 0.55 0.30-1.02 0.060
PreOP CEA Preoperative carcinoembryonic antigen
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prospective studies are needed to confirm our find-
ings. An additional limitation is that the indications
for surgical approach were unclear. There appeared
to be a trend in which patients for whom disease
progression was suspected clinically were converted
to open surgery from the laparoscopic approach be-
cause the indications for laparoscopic surgery were
not clearly established. As mentioned before, Park et
al. [15] reported that the indications for laparoscopic
surgery have expanded with accumulating experience
of surgeon. The laparoscopic approach is carefully
considered for clinically suspected T4 colorectal can-
cer at our institution. We did not analyze the inter-
rater variability between surgeons. Five surgeons were
involved in our study, but only four surgeons per-
formed more than 200 laparoscopic colorectal
Table 4 Predictive factors for DFS according to univariate and multivariate analyses
Univariate analysis Multivariate analysis
HR 95 % CI P-value HR 95 % CI P-value
Age (years)
>60 / ≤ 60 1.79 1.06-3.02 0.028 1.86 1.04-3.31 0.036
Sex
Male / Female 1.11 0.66-1.84 0.702
BMI (kg/m2)
>23 / ≤ 23 1.05 0.64-1.75 0.839
PreOP CEA (ng/ml)
>5 / ≤ 5 2.28 1.34-3.86 0.002 1.87 1.06-3.30 0.032
Previous abdominal operation
+ / - 1.05 0.59-1.89 0.863
Combined resection of an adjacent organ
+ / - 1.40 0.82-2.38 0.217
Tumor location
Rectum / Colon 2.92 1.76-4.87 <0.001 3.25 1.85-5.74 <0.001
Clinical Obstruction
+ / - 1.14 0.67-1.91 0.634
Clinical Perforation
+ / - 1.73 0.82-3.63 0.152
Operative technique
Laparoscopic / Open 0.77 0.40-1.49 0.435
Pathologic T stage
T4 / T2 + T3 1.77 1.07-2.95 0.027 2.22 1.26-3.93 0.006
Pathologic N stage
+ / - 2.20 1.29-3.77 0.004 1.22 0.63-2.36 0.556
Differentiation of cell
PD + MUC + Signet / WD + MD 1.35 0.73-2.50 0.333
Lymphatic invasion
+ / - 1.37 0.80-2.33 0.253
Vascular invasion
+ / - 2.08 1.15-3.75 0.015 1.60 0.79-3.26 0.194
Perineural invasion
+ / - 1.79 0.90-3.56 0.097 0.81 0.38-1.76 0.600
Adjuvant chemotherapy
+ / - 0.65 0.35-1.20 0.169
PreOP CEA Preoperative carcinoembryonic antigen, WD Well differentiated, MD Moderately differentiated, PD Poorly differentiated, MUC Mucinous
adenocarcinoma, signet Signet ring cell type
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surgeries, with the fifth surgeon having performed 50
surgeries before first performing surgery for suspected
T4 colorectal cancer. Randomized controlled trials re-
garding the surgical learning curve should be consid-
ered closely, even when experienced surgeons are
involved. One of the surgeons performed only hand-
assisted laparoscopic surgery. Patients who underwent
neoadjuvant chemoradiotherapy were excluded in this
study because the pathology and surgical circumfer-
ence in the operative field would be different pre-
and post-neoadjuvant chemoradiotherapy [18]. Finally,
the accuracy of the preoperative staging of colorectal
cancer was reported to range from 47.5 to 80 % [19].
However, the positive predictive value for clinical T4
disease might be as low as 19.4 to 51.2 % [11, 20].
The positive predictive value in this study was 37.9 %
(111/293). A relatively large number of patients who
were clinically suspected of having T4 disease were
pathologically shown to have T3 disease. The accur-
acy of predicting T stage via preoperative imaging
modalities might be another limitation of this study.
Conclusions
In conclusion, despite the clinical suspicion of T4 dis-
ease before surgery, laparoscopic colorectal resection for
T4 colorectal cancer can be attempted and has similar
perioperative and long-term oncologic outcomes to
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